Genetically modified mesenchymal stem cells expressing α1-antitrypsin (AAT)

摘要

PROBLEM TO BE SOLVED: To provide a medical agent for treating a medical condition associated with inflammation and / or an undesired immune response in a subject without α1-antitrypsin (AAT) deficiency. A genetically modified mesenchymal stem cell that is (ii) operably linked to a promoter or promoter / enhancer combination and (i) a region encoding α1-antitrypsin (AAT). It is a medical drug containing genetically modified mesenchymal stem cells for use as a medicine, which comprises an exogenous nucleic acid containing. [Selection diagram] None